High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia

Daisuke Tomizawa, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Daisuke Hasegawa, Hiroshi Moritake, Daiichiro Hasegawa, Kiminori Terui, Asahito Hama, Shin-ichi Tsujimoto, Nobutaka Kiyokawa, Hayato Miyachi, Takao Deguchi, Yoshiko Hashii, Yuka Iijima-Yamashita, Tomohiko Taki, Yasushi Noguchi, Kazutoshi Koike, Katsuyoshi Koh, Yuki Yuza, Akiko Moriya Saito, Keizo Horibe, Takashi Taga, Shiro Tanaka, Souichi Adachi

Open source

DOI: 10.1038/s41375-023-02075-9
Published: 2023-11-06
Container: Leukemia
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41375-023-02075-9,
  title = {High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia},
  author = {Daisuke Tomizawa and Jun Matsubayashi and Shotaro Iwamoto and Hidefumi Hiramatsu and Daisuke Hasegawa and Hiroshi Moritake and Daiichiro Hasegawa and Kiminori Terui and Asahito Hama and Shin-ichi Tsujimoto and Nobutaka Kiyokawa and Hayato Miyachi and Takao Deguchi and Yoshiko Hashii and Yuka Iijima-Yamashita and Tomohiko Taki and Yasushi Noguchi and Kazutoshi Koike and Katsuyoshi Koh and Yuki Yuza and Akiko Moriya Saito and Keizo Horibe and Takashi Taga and Shiro Tanaka and Souichi Adachi},
  year = {2023},
  journal = {Leukemia},
  doi = {10.1038/s41375-023-02075-9},
  url = {https://doi.org/10.1038/s41375-023-02075-9}
}

RIS

TY  - JOUR
TI  - High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia
AU  - Daisuke Tomizawa
AU  - Jun Matsubayashi
AU  - Shotaro Iwamoto
AU  - Hidefumi Hiramatsu
AU  - Daisuke Hasegawa
AU  - Hiroshi Moritake
AU  - Daiichiro Hasegawa
AU  - Kiminori Terui
AU  - Asahito Hama
AU  - Shin-ichi Tsujimoto
AU  - Nobutaka Kiyokawa
AU  - Hayato Miyachi
AU  - Takao Deguchi
AU  - Yoshiko Hashii
AU  - Yuka Iijima-Yamashita
AU  - Tomohiko Taki
AU  - Yasushi Noguchi
AU  - Kazutoshi Koike
AU  - Katsuyoshi Koh
AU  - Yuki Yuza
AU  - Akiko Moriya Saito
AU  - Keizo Horibe
AU  - Takashi Taga
AU  - Shiro Tanaka
AU  - Souichi Adachi
PY  - 2023
JO  - Leukemia
DO  - 10.1038/s41375-023-02075-9
UR  - https://doi.org/10.1038/s41375-023-02075-9
ER  -

APA

Tomizawa, D., Matsubayashi, J., Iwamoto, S., Hiramatsu, H., Hasegawa, D., Moritake, H., Hasegawa, D., Terui, K., Hama, A., Tsujimoto, S., Kiyokawa, N., Miyachi, H., Deguchi, T., Hashii, Y., Iijima-Yamashita, Y., Taki, T., Noguchi, Y., Koike, K., Koh, K., Yuza, Y., Saito, A. M., Horibe, K., Taga, T., Tanaka, S., & Adachi, S. (2023). High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia. Leukemia. https://doi.org/10.1038/s41375-023-02075-9

Source records

crossref · retrieved 2026-09-26T11:00:28.317Z